| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6107abcc76ad54b3821249d6315e0ab |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-32 |
| filingDate |
2016-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b0859c29f188b34a1ceaf4a27fc0ead
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_978de4c8a40c18df2bd1118ff237d85b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_783e24a25a310834cfe0bcedcc8c8441
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9e2ec0057a8726fc077ac37a39776ef |
| publicationDate |
2017-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017018382-A1 |
| titleOfInvention |
Cell evaluation method, high-performance cell or drug screening method, and pharmaceutical composition |
| abstract |
The present invention addresses the problem of providing: a method for evaluating whether cells are effective in the treatment of diseases, and the like, associated with intracellular mitochondrial dysfunction and a reduction in mitochondrial activity, and in the amelioration of symptoms associated with aging and the like; high-performance cells judged to be effective by this method; and a method for obtaining a drug capable of inducing such high-performance cells. The present invention is a cell evaluation method for evaluating a cell using, as the indicator, the capability of mitochondrial transference to other cells. Further, mitochondrial activity is preferred as the indicator. The mitochondrial activity is at least one selected from the group consisting of mitochondrial dehydrogenase activity, mitochondrial content, and mitochondrial membrane potential. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022078275-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110438062-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110517776-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110517776-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017170571-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020262970-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111991391-A |
| priorityDate |
2015-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |